Form D · Biotechnology
CytoRecovery, Inc.
Blacksburg, VA · CIK 0001741666
Offering snapshot reported Jul 18, 2022 · SEC filing
- Reported sold
- $2.11M Offering amount: $4M
- Investors reported
- 24 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 11, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 18, 2022 | Initial | $2,105,000 | No comparison | 24 | SEC filing |
| Apr 30, 2021 | Amendment | $1,295,000 | No comparison | Not reported | SEC filing |
| Nov 21, 2019 | Amendment | $725,000 | $550,000vs Apr 22, 2019 | 16 | SEC filing |
| Apr 22, 2019 | Initial | $500,000 | No comparison | 13 | SEC filing |
| Apr 22, 2019 | Initial | $175,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-452737
Source: Form D, filed Jul 18, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vinod Chachra | Director |
| Leonard P. Harris | Director |
| James Ramey | Director |
| Stephen C. Turner | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1872 Pratt Dr., Suite 1350
Blacksburg, VA, 24060
Blacksburg, VA, 24060